Deutsche Bank’s VanEck Biotech ETF BBH Stock Holding History

Deutsche Bank’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-150	Closed	-$19K	–	4880
2019 Q2	$19K	Buy	+150	New	+$18.5K	﹤0.01%	4822
2019 Q1	–	Sell	-300	Closed	-$33K	–	5171
2018 Q4	$33K	Hold	300	–	–	﹤0.01%	4614
2018 Q3	$41K	Hold	300	–	–	﹤0.01%	4766
2018 Q2	$36K	Hold	300	–	–	﹤0.01%	4870
2018 Q1	$36K	Buy	+300	New	+$37.6K	﹤0.01%	4851
2015 Q1	–	Sell	-130	Closed	-$14K	–	5135
2014 Q4	$14K	Sell	130 -300	-70%	-$33.8K	﹤0.01%	5623
2014 Q3	$45K	Sell	430 -1,050	-71%	-$106K	﹤0.01%	4892
2014 Q2	$141K	Sell	1,480 -730	-33%	-$65.4K	﹤0.01%	4361
2014 Q1	$200K	Buy	2,210 +1,370	+163%	+$133K	﹤0.01%	3895
2013 Q4	$74K	Buy	840 +160	+24%	+$13.4K	﹤0.01%	4184
2013 Q3	$56K	Sell	680 -120	-15%	-$9.42K	﹤0.01%	4619
2013 Q2	$54K	Buy	+800	New	+$55.7K	﹤0.01%	4476

Other funds holding BBH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BRM

Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Deutsche Bank's BBH Position: Q3 2019 in Review

Deutsche Bank sold out of VanEck Biotech ETF (BBH) in Q3 2019, closing a stake of 150 shares — an estimated $19K sold.

Deutsche Bank first reported a position in BBH in Q2 2013 and held it in 12 quarters. The position peaked at $200K in Q1 2014. 78 funds tracked by Wall St. Rank hold BBH as of Q3 2019.

Deutsche Bank reported no remaining VanEck Biotech ETF position as of Q3 2019 after selling out during the quarter.
Deutsche Bank sold 150 VanEck Biotech ETF shares in Q3 2019, an estimated $19K.
Deutsche Bank first reported a position in VanEck Biotech ETF in Q2 2013 and held it in 12 quarters.
Deutsche Bank's VanEck Biotech ETF position peaked at $200K in Q1 2014.
78 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2019.

Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.